1. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
   Y. Zhao et al, 2016, Clinical and Translational Oncology CrossRef
2. Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the Expression of Hypoxia-inducible Factor-1 Alpha in Human Retinal Müller Cells
   Young Jun Kim et al, 2017, Korean Journal of Ophthalmology CrossRef
3. Current paradigms in epigenetic anticancer therapeutics and future challenges
   Manoj Singh et al, 2022, Seminars in Cancer Biology CrossRef
4. Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy
   Naoto Iizuka et al, 2018, Journal of Pharmacological Sciences CrossRef
5. Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects
   Huajian Zhu et al, 2022, Journal of Medicinal Chemistry CrossRef
6. Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer
   Nikolaos Garmpis et al, 2019, Pharmacoepigenetics CrossRef
7. The progress of angiogenic factors in the development of leukemias
   Yang Han et al, 2016, Intractable & Rare Diseases Research CrossRef
8. Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression
   Sook-Kyoung Heo et al, 2019, Tumor Biology CrossRef
9. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
   Mohammed I. Y. Elmallah et al, 2019, Cancers CrossRef
10. Heparanase-mediated histone 3 acetylation regulates VEGF gene transcription in the hyperglycemia and hypoxia human retinal endothelial cells
    Xuan Leng et al, 2023, Experimental Eye Research CrossRef
11. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
    Øystein Bruserud et al, 2021, Pharmaceuticals CrossRef
12. Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells
    Aneta Balcerczyk et al, 2016, Biochemical Pharmacology CrossRef
13. The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting
    Luciano Pirola et al, 2018, Cancers CrossRef
14. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
    Flávia Alves Verza et al, 2020, Cancers CrossRef
15. Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC)
    Preethi G. Anantharaju et al, 2017, Cancer Biology & Therapy CrossRef
16. The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
    Amber Blaauboer et al, 2022, Biomedicines CrossRef
17. Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
    Debarati Banik et al, 2019, International Journal of Molecular Sciences CrossRef
18. Natural remedies and functional foods as angiogenesis modulators
    Mehmet Varol, 2020, Functional Foods in Cancer Prevention and Therapy CrossRef